Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Robert C. Mignacca
Observed names:
R C Mignacca,
R Mignacca,
R. Mignacca,
RC Mignacca,
ROBERT MIGNACCA,
Robert C Mignacca,
Robert Mignaca,
Robert Mignacca
show all 8
Institutions:
Dell Children's Medical Center of Central Texas,
The University of Texas at Austin
Observed institutions:
American Red Cross,
University of California, Los Angeles,
Dell Children's Medical Center of Central Texas,
Children's Hospital Central California,
UCLA Jonsson Comprehensive Cancer Center,
The University of Texas at Austin
show all 6
ORCID:
0009-0008-7415-8894
Observed ORCID:
0009-0008-7415-8894
OpenAlex ID:
A5068052344
Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent
2000
·
Sylvia T. Singer
, Vivian Wu
, et al.
·
Blood
·
400
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial
2022
·
Neil A. Goldenberg
, John M. Kittelson
, et al.
·
JAMA
·
112
PDF
Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia
2008
·
Ellen B. Fung
, Paul R. Harmatz
, et al.
·
Bone
·
79
Transcriptional Activation of egr-1 by Granulocyte-Macrophage Colony-stimulating Factor but Not Interleukin 3 Requires Phosphorylation of cAMP Response Element-binding Protein (CREB) on Serine 133
1995
·
Hu-Jung Julie Lee
, Robert C. Mignacca
, et al.
·
Journal of Biological Chemistry
·
70
Fetal haemoglobin augmentation in E/β0 thalassaemia: clinical and haematological outcome
2005
·
Sylvia T. Singer
, Frans A. Kuypers
, et al.
·
British Journal of Haematology
·
64
Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post–2016 CDC Guideline
2024
·
Hyeun Ah Kang
, Bofei Wang
, et al.
·
JAMA Internal Medicine
·
35
PDF
Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease
2022
·
Hyeun Ah Kang
, Jamie C. Barner
, et al.
·
American Journal of Hematology
·
30
Signal transduction by granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors.
1994
·
K M Sakamoto
, R C Mignacca
, et al.
·
PubMed
·
26
Single and Combination Drug Therapy for Fetal Hemoglobin Augmentation in Hemoglobin E‐β0‐Thalassemia: Considerations for Treatment
2005
·
SYLVIA T. SINGER
, FRANS A. KUYPERS
, et al.
·
Annals of the New York Academy of Sciences
·
15
Mechanism of transcriptional activation of the immediate early gene Egr- 1 in response to PIXY321
1996
·
RC Mignacca
, HJ Lee
, et al.
·
Blood
·
14
PDF
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years
2024
·
Neil A. Goldenberg
, Sam Schulman
, et al.
·
Journal of Thrombosis and Haemostasis
·
10
PDF
Telehealth Use Among Medicaid-Enrolled Children with Sickle Cell Disease Before and During the COVID-19 Pandemic
2025
·
Gloria N. Odonkor
, Hyeun Ah Kang
, et al.
·
Healthcare
·
5
PDF
Unintended Consequences of the CDC’s 2016 Opioid Guideline on Individuals With Sickle Cell Disease
2023
·
Hyeun Ah Kang
, Bofei Wang
, et al.
·
American Journal of Pharmaceutical Education
·
1
SA66 Patient Demographic and Clinical Characteristics Associated With the Use of the Newly Approved Disease-Modifying Medications for Sickle Cell Disease
2024
·
Y Zhang
, HA Kang
, et al.
·
Value in Health
HSD37 Prescribing Trends of Newly Approved Sickle Cell Disease-Modifying Medications
2024
·
Y Zhang
, HA Kang
, et al.
·
Value in Health
Telehealth Use Among Adults with Sickle Cell Disease before and during the COVID-19 Pandemic in the United States
2023
·
Hyeun Ah Kang
, Xueye Yan
, et al.
·
Blood
PDF
Pro40 Association Between Hydroxyurea Medication Adherence and All-cause and Disease-related Healthcare Expenditures Among Texas Medicaid Enrollees With Sickle Cell Disease
2019
·
H.A. Kang
, J.C. Barner
, et al.
·
Value in Health
Association Between Hydroxyurea Medication Adherence and Vaso-Occlusive Crisis Events Among Texas Medicaid Enrollees with Sickle Cell Disease
2018
·
HA Kang
, JC Barner
, et al.
·
Value in Health
Effect of hydroxyurea treatment on erythropoiesis and RBC characteristics in E-beta thalassemia
2001
·
Sylvia T. Singer
, Frans A. Kuypers
, et al.
Show more works
View as search
Works count:
19
Citation count:
861
H-index:
10
I10-index:
11
Year
Topic
Type